Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.68
-0.56
-0.45
-0.33

Details

Expected EPS
-0.359333
Actual EPS
-0.45
Surprise EPS
-0.09
Surprise Percent
+25.23%

Description

Acumen Pharmaceuticals (ABOS) has reported earnings of -0.45 per share for Q3 2026.

0 Comments

Share your thoughts